Lv4
458 积分 2025-05-20 加入
随便写些什么也不能刷下存在感
Supportive care for systemic amyloidosis: International Society of Amyloidosis (ISA) expert panel guidelines
1天前
已完结
Development of lymph node metastasis-related prognostic markers in breast cancer
13天前
已完结
Phase III ATTR-CM Trials: Rethinking the “Placebo” Arm
17天前
已完结
Game-changing breakthroughs to redefine the landscape of the renin–angiotensin–aldosterone system in health and disease
23天前
已完结
Descriptive epidemiology of female breast cancer around the world: incidence, mortality, and sociodemographic risks and disparities
24天前
已完结
Proton therapy in breast cancer: bridging medical and radiation oncology
28天前
已关闭
New triple combination therapy approach for children with advanced heart failure despite having received standard heart failure treatment
29天前
已关闭
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Stage II and III High-Risk Early Breast Cancer Treatment Setting
1个月前
已完结
Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2− breast cancer and residual disease after neoadjuvant chemotherapy
1个月前
已完结
NYC’s Overdose Prevention Centers: Data from the First Year of Supervised Consumption Services
1个月前
已关闭
皖公网安备34019202002308
